Aileron Therapeutics

About:

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

Website: http://www.aileronrx.com

Top Investors: Apple Tree Partners, Biotechnology Value Fund, SR One, Nantahala Capital Management, Lincoln Park Capital Fund

Description:

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.

Total Funding Amount:

$256M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)aileronrx.com

Founders:

Joseph A. Yanchik III, Rosana Kapeller

Number of Employees:

11-50

Last Funding Date:

2024-05-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai